Aberdeen Pain Research Collaboration (Epidemiology Group), School of Medicine and Dentistry, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen AB25 2ZD, UK.
Rheumatology (Oxford). 2011 May;50(5):911-20. doi: 10.1093/rheumatology/keq379. Epub 2010 Dec 17.
Objectives. To critically evaluate the evidence regarding complementary and alternative medicine (CAM) taken orally or applied topically (excluding glucosamine and chondroitin) in the treatment of OA. Methods. Randomized clinical trials of OA using CAMs, in comparison with other treatments or placebo, published in English up to January 2009, were eligible for inclusion. They were identified using systematic searches of bibliographic databases and manual searching of reference lists. Information was extracted on outcomes, and statistical significance, in comparison with alternative treatment of placebo, and side effects were reported. The methodological quality of the primary studies was determined. Results. The present review found consistent evidence that capsaicin gel and S-adenosyl methionine were effective in the management of OA. There was also some consistency to the evidence that Indian Frankincense, methylsulphonylmethane and rose hip may be effective. For other substances with promising evidence, the evidence base was either insufficiently large or the evidence base was inconsistent. Most of the CAM compounds studied were free of major adverse effects. Conclusion. The major limitation in reviewing the evidence is the paucity of randomized controlled trials in the area: widening the evidence base, particularly for those compounds for which there is promising evidence, should be a priority for both researchers and funders.
目的。 批判性评估口服或局部(不包括葡萄糖胺和软骨素)使用的补充和替代医学(CAM)治疗 OA 的证据。 方法。 纳入符合条件的使用 CAM 治疗 OA 的随机临床试验,与其他治疗或安慰剂进行比较,发表于 2009 年 1 月前的英文文献。通过系统搜索书目数据库和手动搜索参考文献列表来确定这些文献。提取与替代治疗或安慰剂相比的结果和统计学意义,并报告副作用。主要研究的方法学质量也进行了评估。 结果。 本综述发现一致的证据表明辣椒素凝胶和 S-腺苷甲硫氨酸在 OA 管理中有效。印度乳香、甲基磺酰甲烷和玫瑰果可能有效,这也有一定的一致性证据。对于其他有前景的证据的物质,证据基础要么不够大,要么证据基础不一致。研究的大多数 CAM 化合物没有主要的不良反应。 结论。 审查证据的主要限制是该领域随机对照试验的缺乏:扩大证据基础,特别是对于那些有前景的证据的化合物,应该是研究人员和资助者的优先事项。